European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Magnetic Nanohybrids for Cancer Therapy

Descrizione del progetto

Collaborazione per le nanoparticelle nella terapia del cancro

La nanotecnologia, lo studio delle particelle estremamente piccole, ha un immenso potenziale applicativo nella ricerca medica. Le nanoparticelle di ossido di ferro avranno un ruolo importante nella terapia del cancro, nella diagnosi e nella chirurgia in un prossimo futuro. Il progetto MaNaCa creerà una base per la ricerca e l’efficienza scientifica e tecnologica. L’Institute of the National Academy of Sciences (IPR-NAS) in Armenia collaborerà in rete con l’Università Aristotele di Salonicco in Grecia e l’Università tedesca di Duisburg-Essen. Insieme, saranno supportati dalla società di consulenza Intelligentsia Consultants Sarl sull’argomento dei nanoibridi magnetici utilizzati nella terapia del cancro per tre anni.

Obiettivo

The MaNaCa project intends to develop the scientific and technological capacity as well as raising the research profile of the Institute for Physical Research of the National Academy of Sciences (IPR-NAS) in Armenia. From a scientific standpoint, MaNaCa will focus on the structural and magnetic characterization of magnetic nanohybrids and their application for cancer therapy. The project's aim will be accomplished by networking IPR-NAS with two internationally-leading research organisations: the Aristotle University of Thessaloniki (AUTH) in Greece and the University of Duisburg – Essen (UDE) in Germany. Throughout the project, the research partners will be supported for management ad dissemination by Intelligentsia Consultants Sàrl (INT), a consultancy company based in Luxembourg which has already collaborated on several occasions with the Widening partner. During the project, which will have a total duration of three years, the partners will carry out a research and innovation strategy with these objectives:

1. Stimulating scientific excellence and innovation capacity of IPR-NAS with regard to magnetic nanohybrids for cancer therapy.
2. Improve the career prospects of early stage researchers of IPR-NAS and the Twinning partners
3. Raise the research profile of IPR-NAS and the Twinning Partners

In order to accomplish this task, the consortium partners will implement several actions through the project’s work packages: (WP1) exchange of senior researchers; (WP2) exchange of early stage researchers; and (WP3) dissemination and oureach. Project management (WP4) will be coordinated by IPR-NAS with the support of INT. In addition to staff exchanges, project's activities will include technical training, joint publications, joint participation to conferences, organization of summer schools, workshops and an international conference.

Invito a presentare proposte

H2020-WIDESPREAD-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-WIDESPREAD-2018-03

Meccanismo di finanziamento

CSA - Coordination and support action

Coordinatore

INSTITUTE FOR PHYSICAL RESEARCH OF NATIONAL ACADEMY OF SCIENCES OF ARMENIA
Contribution nette de l'UE
€ 356 662,50
Costo totale
€ 356 662,50

Partecipanti (3)